Li D - Search Results

1

Development of the nonreceptor tyrosine kinase FER-targeting PROTACs as a potential strategy for antagonizing ovarian cancer cell motility and invasiveness.

Zhang Y, Xiong X, Sun R, Zhu X, Wang C, Jiang B, Yang X, Li D, Fan G. Zhang Y, et al. Among authors: li d. J Biol Chem. 2023 Jun;299(6):104825. doi: 10.1016/j.jbc.2023.104825. Epub 2023 May 16. J Biol Chem. 2023. PMID: 37196766 Free PMC article.

2

Protein tyrosine phosphatase receptor type R (PTPRR) antagonizes the Wnt signaling pathway in ovarian cancer by dephosphorylating and inactivating β-catenin.

Wang Y, Cao J, Liu W, Zhang J, Wang Z, Zhang Y, Hou L, Chen S, Hao P, Zhang L, Zhuang M, Yu Y, Li D, Fan G. Wang Y, et al. Among authors: li d. J Biol Chem. 2019 Nov 29;294(48):18306-18323. doi: 10.1074/jbc.RA119.010348. Epub 2019 Oct 25. J Biol Chem. 2019. PMID: 31653698 Free PMC article.

3

NAD⁺ supplement potentiates tumor-killing function by rescuing defective TUB-mediated NAMPT transcription in tumor-infiltrated T cells.

Wang Y, Wang F, Wang L, Qiu S, Yao Y, Yan C, Xiong X, Chen X, Ji Q, Cao J, Gao G, Li D, Zhang L, Guo Z, Wang R, Wang H, Fan G. Wang Y, et al. Among authors: li d. Cell Rep. 2021 Aug 10;36(6):109516. doi: 10.1016/j.celrep.2021.109516. Cell Rep. 2021. PMID: 34380043 Free article.

4

FER-mediated phosphorylation and PIK3R2 recruitment on IRS4 promotes AKT activation and tumorigenesis in ovarian cancer cells.

Zhang Y, Xiong X, Zhu Q, Zhang J, Chen S, Wang Y, Cao J, Chen L, Hou L, Zhao X, Hao P, Chen J, Zhuang M, Li D, Fan G. Zhang Y, et al. Among authors: li d. Elife. 2022 May 12;11:e76183. doi: 10.7554/eLife.76183. Elife. 2022. PMID: 35550247 Free PMC article.

5

Minimizing DNA trapping while maintaining activity inhibition via selective PARP1 degrader.

Chen L, Zou Y, Sun R, Huang M, Zhu X, Tang X, Yang X, Li D, Fan G, Wang Y. Chen L, et al. Among authors: li d. Cell Death Dis. 2024 Dec 18;15(12):898. doi: 10.1038/s41419-024-07277-2. Cell Death Dis. 2024. PMID: 39695097 Free PMC article.

6

Integrated Microfluidic Device for Accurate Extracellular Vesicle Quantification and Protein Markers Analysis Directly from Human Whole Blood.

Zhou S, Hu T, Zhang F, Tang D, Li D, Cao J, Wei W, Wu Y, Liu S. Zhou S, et al. Among authors: li d. Anal Chem. 2020 Jan 7;92(1):1574-1581. doi: 10.1021/acs.analchem.9b04852. Epub 2019 Dec 10. Anal Chem. 2020. PMID: 31779307

7

Research Status and Progress of Nutritional Support Therapy for Ovarian Cancer.

Wu Y, Mu J, Cao J, Li D, Dai Y. Wu Y, et al. Among authors: li d. Nutr Cancer. 2022;74(5):1519-1526. doi: 10.1080/01635581.2021.1957132. Epub 2021 Jul 29. Nutr Cancer. 2022. PMID: 34323140

8

Progress in Applicability of Scoring Systems Based on Nutritional and Inflammatory Parameters for Ovarian Cancer.

Mu J, Wu Y, Jiang C, Cai L, Li D, Cao J. Mu J, et al. Among authors: li d. Front Nutr. 2022 Apr 8;9:809091. doi: 10.3389/fnut.2022.809091. eCollection 2022. Front Nutr. 2022. PMID: 35464000 Free PMC article. Review.

9

A signature based on glycosyltransferase genes provides a promising tool for the prediction of prognosis and immunotherapy responsiveness in ovarian cancer.

Xu X, Wu Y, Jia G, Zhu Q, Li D, Xie K. Xu X, et al. Among authors: li d. J Ovarian Res. 2023 Jan 7;16(1):5. doi: 10.1186/s13048-022-01088-9. J Ovarian Res. 2023. PMID: 36611197 Free PMC article.

10

Exosome-transmitted miR-30a-5p enhances cell proliferation, migration, and invasion in ovarian cancer.

Cao J, Wang H, Yang J, Zhang J, Li D, Xu P. Cao J, et al. Among authors: li d. Cell Div. 2023 Nov 1;18(1):20. doi: 10.1186/s13008-023-00099-2. Cell Div. 2023. PMID: 37915096 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53,101 results

Search Page

Filters